Helicobacter Pylori Eradication for Primary Prevention of Upper Gastrointestinal Ulcer Bleeding in Older Patients Prescribed Aspirin (HEAT): A Randomised Placebo-Controlled Trial in Primary Care

医学 兰索拉唑 内科学 幽门螺杆菌 阿司匹林 安慰剂 人口 克拉霉素 随机对照试验 尿素呼气试验 胃肠病学 替代医学 幽门螺杆菌感染 环境卫生 病理
作者
C J Hawkey,Anthony John Avery,Carol A. C. Coupland,Colin John Crooks,Jennifer Dumbleton,Richard F. Hobbs,Denise Kendrick,Michael V Moore,Clive Dylan Morris,Greg P Rubin,Murray Donald Smith,Diane Stevenson,David CA Mant,Alexander Charles Ford,Thomas MacLennan MacDonald,Mike J Bradburn,Claire A Klauza,Angela C. Shone,Richard F. Logan,Jonathan James Deeks
出处
期刊:The Lancet [Elsevier BV]
卷期号:400 (10363): 1597-1606 被引量:98
标识
DOI:10.1016/s0140-6736(22)01843-8
摘要

BACKGROUND: Peptic ulcers in patients receiving aspirin are associated with Helicobacter pylori infection. We aimed to investigate whether H pylori eradication would protect against aspirin-associated ulcer bleeding. METHODS: We conducted a randomised, double-blind, placebo-controlled trial (Helicobacter Eradication Aspirin Trial [HEAT]) at 1208 primary care centres in the UK, using routinely collected clinical data. Eligible patients were aged 60 years or older who were receiving aspirin at a daily dose of 325 mg or less (with four or more 28-day prescriptions in the past year) and had a positive C13 urea breath test for H pylori at screening. Patients receiving ulcerogenic or gastroprotective medication were excluded. Participants were randomly assigned (1:1) to receive either a combination of oral clarithromycin 500 mg, metronidazole 400 mg, and lansoprazole 30 mg (active eradication), or oral placebo (control), twice daily for 1 week. Participants, their general practitioners and health-care providers, and the research nurses, trial team, adjudication committee, and analysis team were all masked to group allocation throughout the trial. Follow-up was by scrutiny of electronic data in primary and secondary care. The primary outcome was time to hospitalisation or death due to definite or probable peptic ulcer bleeding, and was analysed by Cox proportional hazards methods in the intention-to-treat population. This trial is registered with EudraCT, 2011-003425-96. FINDINGS: Between Sept 14, 2012, and Nov 22, 2017, 30 166 patients had breath testing for H pylori, 5367 had a positive result, and 5352 were randomly assigned to receive active eradication (n=2677) or placebo (n=2675) and were followed up for a median of 5·0 years (IQR 3·9-6·4). Analysis of the primary outcome showed a significant departure from proportional hazards assumptions (p=0·0068), requiring analysis over separate time periods. There was a significant reduction in incidence of the primary outcome in the active eradication group in the first 2·5 years of follow-up compared with the control group (six episodes adjudicated as definite or probable peptic ulcer bleeds, rate 0·92 [95% CI 0·41-2·04] per 1000 person-years vs 17 episodes, rate 2·61 [1·62-4·19] per 1000 person-years; hazard ratio [HR] 0·35 [95% CI 0·14-0·89]; p=0·028). This advantage remained significant after adjusting for the competing risk of death (p=0·028) but was lost with longer follow-up (HR 1·31 [95% CI 0·55-3·11] in the period after the first 2·5 years; p=0·54). Reports of adverse events were actively solicited; taste disturbance was the most common event (787 patients). INTERPRETATION: H pylori eradication protects against aspirin-associated peptic ulcer bleeding, but this might not be sustained in the long term. FUNDING: National Institute for Health and Care Research Health Technology Assessment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小冯同学完成签到,获得积分10
刚刚
鸿鹄发布了新的文献求助10
刚刚
天气不错发布了新的文献求助10
1秒前
啊熙发布了新的文献求助10
2秒前
科研通AI6.2的应助被跳跃的访琴采纳,获得100
2秒前
3秒前
风中谷南完成签到,获得积分10
3秒前
小蘑菇的应助被fmh采纳,获得10
3秒前
5秒前
Lucas的应助被猪猪侠采纳,获得30
6秒前
cmc完成签到,获得积分10
7秒前
Felix_Li发布了新的文献求助30
8秒前
8秒前
9秒前
10秒前
烟花的应助被TianYee采纳,获得30
11秒前
Nole的应助被王博林采纳,获得10
11秒前
11秒前
晚风发布了新的文献求助10
11秒前
wanci的应助被djbj2022采纳,获得10
11秒前
机智宛亦完成签到 ,获得积分10
12秒前
Atlantis30发布了新的文献求助10
12秒前
chemistry完成签到,获得积分10
13秒前
23331完成签到,获得积分10
14秒前
李义志发布了新的文献求助10
15秒前
15秒前
16秒前
16秒前
小蘑菇的应助被joe采纳,获得10
16秒前
爆米花的应助被务实道罡采纳,获得10
17秒前
完美世界的应助被wg采纳,获得10
17秒前
Zz发布了新的文献求助10
17秒前
牧百川发布了新的文献求助10
17秒前
17秒前
滑稽剑客发布了新的文献求助10
17秒前
18秒前
文思完成签到,获得积分10
18秒前
Nole的应助被单薄冰安采纳,获得10
19秒前
fmh发布了新的文献求助10
20秒前
柚子完成签到 ,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188724
求助须知:如何正确求助?哪些是违规求助? 9576405
关于积分的说明 21847400
捐赠科研通 7786785
什么是DOI,文献DOI怎么找? 3435402
关于科研通互助平台的介绍 2559647
邀请新用户注册赠送积分活动 2482363